re: big us rally in biotechs and drugs Just start to realize that the co now has Pfizer and Sanofi salesforces behind which are quite big. Also the co is treating at a nice profit only 0.5 % of possible eligible US patients and about 0.25 % of eligible patients worldwide so ther is big growth avenues ahead and expansion of P.E ratio
topper's finally got some new material, page-66
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.40M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $61.98K | 351.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 11238850 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1266857 | 36 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |